Institutional investors purchased a net $8.8 million shares of ZIOP during the quarter ended March 2017, and now own 42.06% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HEIGHTS CAPITAL MANAGEMENT, INC. Bought 9.7 Million shares of ZIOPHARM Oncology Inc
THE VANGUARD GROUP, INC. Bought 396.7 Thousand shares of ZIOPHARM Oncology Inc
MORGAN STANLEY & CO. LLC Bought 285.0 Thousand shares of ZIOPHARM Oncology Inc